Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
Emuri AbeLambert AssoumouPierre de TruchisKarine AmatSéverine GibowskiGuillaume GrasJonathan BelletJuliette SaillardChristine KatlamaDominique CostagliolaPierre-Marie GirardRoland LandmanJean Claude AlvarezPublished in: British journal of clinical pharmacology (2020)
Despite low/undetectable PI/NNRTI plasma concentrations in the OFF period, patients maintained an undetectable viral load. The mechanistic explanation should be investigated.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- end stage renal disease
- hiv aids
- ejection fraction
- hiv infected patients
- chronic kidney disease
- newly diagnosed
- hepatitis c virus
- clinical trial
- study protocol
- hiv testing
- men who have sex with men
- phase iii
- electronic health record
- phase ii
- south africa
- patient reported outcomes
- machine learning
- high resolution
- artificial intelligence
- single molecule